New York, NY -- (SBWIRE) -- 01/03/2013 -- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) 2.38 +0.17 (7.69%).
The company, on Dec. 17, said it received fast-track status from the U.S. Food and Drug Administration for the development of LX1033, an orally delivered small molecule drug candidate for diarrhea-predominant irritable bowel syndrome. The biopharmaceutical company said LX1033, an inhibitor of tryptophan hydroxylase that acts locally in the gastrointestinal tract, is currently being evaluated in a Phase 2 clinical trial. Results are expected in the first half of next year.
Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease.
Find out where LXRX could be headed by getting the free full report here: http://www.monstertradingalerts.com/market-scan/?symbol=LXRX
ProShares UltraPro S&P 500 (ETF) (NYSE: UPRO) 94.81 +6.95 (7.91%), Range - 92.34 - 94.84, 52 week - 61.35 - 97.02, Vol. - 565,539.00.
This Ultra ProShares ETF seeks a return that is 3x the return of an index or other benchmark (target) for a single day, as measured from one NAV calculation to the next. Due to the compounding of daily returns, ProShares&apos returns over periods other than one day will likely differ in amount and possibly direction from the target return for the same period. These effects may be more pronounced in funds with larger or inverse multiples and in funds with volatile benchmarks.
Find out more about UPRO by getting the free full report here: http://www.monstertradingalerts.com/market-scan/?symbol=UPRO
MonsterTradingAlerts.com issues momentum alerts on stocks that can provide gains to day traders. MonsterTradingAlerts.com provides members with timely information and exclusive alerts on cheap and under-valued stocks in the United States with the potential to deliver gains of 100% - 200% or more. MonsterTradingAlerts.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals MonsterTradingAlerts.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. Gain an Edge by joining the MonsterTradingAlerts.com newsletter and receiving alerts from a Pro-Active team of researchers. Trading Alerts believes traders should have a chance at successfully trading penny stocks and invites traders and investors to be part of the Free VIP membership.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.MonsterTradingAlerts.com
Disclosure: MonsterTradingAlerts.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit MonsterTradingAlerts.com website, for complete risks and disclosures.
Investor Alley, its employees, officers, directors, shareholders and affiliates, hold no positions in the above-mentioned stocks.
Alexander K. Neumann
Monster Trading Alerts
For more information on this press release visit: http://www.sbwire.com/press-releases/morning-follow-up-on-high-profile-stocks-nasdaq-lxrx-nyse-upro-192967.htm